Remote Cardiac Safety Monitoring through the Lens of the FDA Biomarker Qualification Evidentiary Criteria Framework: A Case Study Analysis
Clinical safety findings remain one of the reasons for attrition of drug candidates during clinical development. Cardiovascular liabilities are not consistently detected in early-stage clinical trials and often become apparent when drugs are administered chronically for extended periods of time. Vit...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Karger Publishers
2021-04-01
|
| Seri Bilgileri: | Digital Biomarkers |
| Konular: | |
| Online Erişim: | https://www.karger.com/Article/FullText/515110 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|